SLP · As filed with the SEC
Simulations Plus cash flow statement, by quarter
The statement as Simulations Plus presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS · USD thousands
| USD thousands | Q3 FY26† 3 months ended May 31, 2026 | Q2 FY26† 3 months ended Feb 28, 2026 | Q1 FY26 3 months ended Nov 30, 2025 | Q4 FY25† 3 months ended Aug 31, 2025 | Q3 FY25† 3 months ended May 31, 2025 | Q2 FY25† 3 months ended Feb 28, 2025 | Q1 FY25 3 months ended Nov 30, 2024 | Q4 FY24† 3 months ended Aug 31, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities | ||||||||
| Net income (loss) | 3,575† | 4,535† | 676 | (681)† | (67,317)† | 3,074† | 206 | 843† |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities | ||||||||
| Depreciation and amortization | 1,368† | 1,547† | 1,346 | 1,354† | 2,318† | 2,274† | 2,265 | 2,206† |
| Change in fair value of contingent consideration | 0† | — | — | 0† | 0† | (640)† | 0 | (1,369)† |
| Discharge of holdback obligation related to Immunetrics acquisition | 0† | — | — | 0† | 0† | — | — | 0† |
| Amortization of investment premiums | 106† | (99)† | 0 | 0† | (4)† | (21)† | (39) | (31)† |
| Stock-based compensation | 1,656† | 1,623† | 1,615 | 1,524† | 1,414† | 1,692† | 1,724 | 1,596† |
| Deferred income taxes | 421† | 17† | 168 | 2,655† | (7,174)† | (947)† | 40 | (399)† |
| Loss from disposal of assets | (6)† | 0† | 75 | 0† | 23† | 0† | — | 0† |
| Currency translation adjustments | — | — | — | — | — | — | — | 20† |
| Unrealized gains (losses) on available-for-sale securities | — | — | 0 | — | — | — | (4) | — |
| Impairments | — | — | — | 0† | — | — | — | 0† |
| Currency translation adjustments | 10† | 11† | (6) | 3† | 40† | (26)† | 42 | 20† |
| (Increase) decrease in | ||||||||
| Accounts receivable | 968† | (6,016)† | (2,437) | 5,063† | 1,713† | (3,689)† | (3,668) | 3,072† |
| Prepaid income taxes | 406† | 1,076† | 32 | (823)† | 421† | 952† | (130) | (995)† |
| Prepaid expenses and other current assets | (1,001)† | 1,706† | (835) | (80)† | (102)† | (332)† | 708 | (645)† |
| Increase (decrease) in | ||||||||
| Accounts payable | 1,431† | (60)† | 393 | (1,193)† | 457† | 86† | 518 | (991)† |
| Other liabilities | 27† | 2,261† | 184 | (587)† | (1,864)† | 3,359† | (4,095) | (746)† |
| Accrued income taxes | — | — | — | — | — | — | — | 0† |
| Deferred revenue | (252)† | (189)† | 3,023 | (1,648)† | 998† | 115† | 1,235 | (897)† |
| Net cash provided by operating activities | 8,709† | 6,412† | 4,234 | 5,587† | 8,144† | 5,669† | (1,274) | 1,664† |
| Cash flows from investing activities | ||||||||
| Purchases of property and equipment | (93)† | (46)† | 0 | (264)† | (297)† | (66)† | (86) | (16)† |
| Purchase of short-term investments | (12,172)† | (10,516)† | (5,500) | 0† | (1,500)† | (1,500)† | (3,500) | 0† |
| Proceeds from maturities of short-term investments | 13,501† | 0† | 1,500 | 0† | 10,397† | 2,120† | 1,500 | (4)† |
| Proceeds from sales of investments | 0† | — | — | 0† | 0† | — | — | 0† |
| Purchase of long-term investments | — | — | — | — | 0† | — | — | — |
| Purchased intangibles | 0† | 0† | (11) | (11)† | (26)† | (156)† | (186) | (33)† |
| Net working capital & excess cash settlement - Pro-ficiency acquisition | 0† | 0† | 0 | — | 0† | 0† | 227 | — |
| Capitalized computer software development costs | (668)† | (786)† | (889) | (516)† | (767)† | (709)† | (639) | (674)† |
| Net cash (used in) provided by investing activities | 878† | (11,348)† | (4,900) | (1,791)† | 7,807† | 684† | (3,138) | (99,500)† |
| Cash flows from financing activities | ||||||||
| Payment of dividends | — | — | — | 0† | 0† | 0† | 0 | (1,202)† |
| Payments on contracts payable | 0† | — | — | 0† | 0† | — | — | 0† |
| Proceeds from the exercise of stock options | 10† | 474† | 2 | 107† | 7† | 28† | 288 | 257† |
| Repurchase and retirement of common shares | — | — | — | — | — | — | — | 0† |
| Net cash provided by (used in) financing activities | 10† | 474† | 2 | 107† | 7† | (1,548)† | 288 | (945)† |
| Net decrease in cash and cash equivalents | — | — | — | — | — | — | (4,124) | (98,781)† |
| Net increase in cash and cash equivalents | 9,597† | (4,462)† | (664) | 3,903† | 15,958† | 4,805† | — | (98,781)† |
| Cash and cash equivalents, beginning of period | 25,727 | 30,189 | 30,853 | 26,950 | 10,992 | 6,187 | 10,311 | 109,092 |
| Cash and cash equivalents, end of period | 35,324 | 25,727 | 30,189 | 30,853 | 26,950 | 10,992 | 6,187 | 10,311 |
| Supplemental disclosures of cash flow information | ||||||||
| Income taxes paid | 404† | 208† | 144 | 140† | 404† | 504† | 112 | 1,475† |
| Supplemental disclosures of non-cash activities | ||||||||
| Measurement period adjustments | — | — | — | 0† | — | — | — | 0† |
| Non-cash investing and financing activities | ||||||||
| Right of use assets capitalized | 47† | 0† | 0 | 426† | (451)† | 0† | 451 | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.